During the past 12 months, Tonix Pharmaceuticals Holding's average Book Value per Share Growth Rate was -89.40% per year.
During the past 3 years, the average Book Value per Share Growth Rate was -72.30% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -77.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Tonix Pharmaceuticals Holding was -57.50% per year. The lowest was -89.00% per year. And the median was -81.80% per year.
Competitive Comparison of Tonix Pharmaceuticals Holding's 3-Year Book Growth Rate
For the Biotechnology subindustry, Tonix Pharmaceuticals Holding's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tonix Pharmaceuticals Holding's 3-Year Book Growth Rate Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Tonix Pharmaceuticals Holding's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Tonix Pharmaceuticals Holding's 3-Year Book Growth Rate falls into.
Tonix Pharmaceuticals Holding 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
Tonix Pharmaceuticals Holding (NAS:TNXP) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Tonix Pharmaceuticals Holding 3-Year Book Growth Rate Related Terms
Thank you for viewing the detailed overview of Tonix Pharmaceuticals Holding's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Tonix Pharmaceuticals Holding (Tonix Pharmaceuticals Holding) Business Description
Tonix Pharmaceuticals Holding Corp is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines to treat and prevent human disease and alleviate suffering. its portfolio consists of the central nervous system, rare disease, immunology, and infectious disease product candidates. The CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions. CNS product candidate is TNX-102 SL, a proprietary sublingual tablet formulation of cyclobenzaprine (CBP) designed for bedtime administration.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNXP has been successfully added to your